Advanced search
Publication Cover
Future Oncology Volume 5, 2009 - Issue 9
Submit an article Journal homepage
1,021
Views
0
CrossRef citations to date
0
Altmetric
Editorial

Stereotactic Body Radiation Therapy for Recurrent Head & Neck Cancers: Rethinking Nonoperative Salvage Strategies

Dwight E HeronAssociate Professor & Vice Chairman Director of Radiation Services, Department of Radiation Oncology, University of Pittsburgh Cancer Institute, University of Pittsburgh School of Medicine, Pittsburgh, PA15232, USA. [email protected]View further author information
Pages 1321-1325 | Published online: 10 Nov 2009

Bibliography

  • Jemal A , SiegelR, WardE, HaoY, XuJ, ThunMJ: Cancer Statistics 2009.CA Cancer J. Clin.59, 225–249 (2009).
  • Stell PM : Survival times in end-stage head and neck cancer.Eur. J. Surg. Oncol.15, 407–410 (1989).
  • Forastiere AA , MetchB, SchullerDEet al.: Randomised comparison of cisplatin plus fluorouracil and carboplatin plus fluorouracil versus methotrexate in advanced squamous-cell carcinoma of the head and neck. A Southwest Oncology Group study.J. Clin. Oncol.10, 1245–1251 (1992).
  • Vokes EE , MickR, KiesMSet al.: Pharmacodynamics of fluorouracil-based induction chemotherapy in advanced head and neck cancer.J. Clin. Oncol.14, 1663–1671 (1996).
  • Clavel M , VermorkenJB, CognettiFet al.: Randomized comparison of cisplatin, methotrexate, bleomycin and vincristine (CABO) versus cisplatin and 5-fluorouracil (CF) versus cisplatin (C) in recurrent or metastatic squamous cell carcinoma of the head and neck. A Phase III study of the EORTC Head and Neck Cancer Cooperative Group.Ann. Oncol.5, 521–526 (1994).
  • Jacobs C , LymanG, Velez-GarciaEet al.: A Phase II randomized study comparing cisplatin and fluorouracil as single agents and in combination for advanced squamous cell carcinoma of the head and neck. J. Clin. Oncol.10, 257–263 (1992).
  • Karamouzis MV , FriedlandD, JohnsonR, RajasenanK, BranstetterB, ArgirisA: Phase II trial of pemetrexed (P) and bevacizumab (B) in patients (pts) with recurrent or metastatic head and neck squamous cell carcinoma (HNSCC): an interim analysis.J. Clin. Oncol.25(185), 6049 (2007).
  • Pomp J , LevendagPC, Van PuttenWL: Reirradiation of recurrent tumors in the head and neck.Am. J. Clin. Oncol.11, 543–549 (1988).
  • Emami B , PerezCA: Combination of surgery, irradiation, and hyperthermia in treatment of recurrences of malignant tumors.Int. J. Radiat. Oncol. Biol. Phys.13, 611–613 (1987).
  • Langlios D , EschwegeF, KramarA, RichardJM: Re-irradiation of recurrent tumors in the head and neck.Radiother. Oncol.3, 27–33 (1985).
  • Salama JK , VokesEE, ChmuraSJet al.: Long-term outcome of concurrent chemotherapy and reirradiation for recurrent and second primary head-and-neck squamous cell carcinoma.Int. J. Radiat. Oncol. Biol. Phys.64, 382–391 (2006).
  • Stevens KR Jr , BritschA, MossWT: High-dose re-irradiation of head and neck cancer with curative intent.Int. J. Radiat. Oncol. Biol. Phys.29, 687–698 (1994).
  • Langer CJ , HarrisJ, HorwitzEMet al.: Phase II study of low-dose paclitaxel and cisplatin in combination with split-course concomitant twice-daily reirradiation in recurrent squamous cell carcinoma of the head and neck: results of Radiation Therapy Oncology Group Protocol 9911.J. Clin. Oncol.25, 4800–4805 (2007).
  • Lu TX , MaiWY, TehBSet al.: Initial experience using intensity-modulated radiotherapy for recurrent nasopharyngeal carcinoma.Int. J. Radiat. Oncol. Biol. Phys.58, 682–687 (2004).
  • Voynov G , HeronDE, BurtonSet al.: Frameless stereotactic radiosurgery for recurrent head and neck carcinoma.Technol. Cancer. Res. Treat.5, 529–535 (2006).
  • Heron DE , FerrisRL, KaramouzisMet al.: Stereotactic body radiotherapy for recurrent squamous cell carcinoma of the head and neck: results of a Phase I dose-escalation trial.Int. J. Radiat. Oncol. Biol. Phys. DOI: 10.1016/j.ijrob.2008.12.075 (2009) (Epub ahead of print).
  • Siddiqui F , PatelM, KhanMet al.: Stereotactic body radiation therapy for primary, recurrent, and metastatic tumor in the head-and-neck region.Int. J. Radiat. Oncol. Biol. Phys.74, 1047–1053 (2009).
  • Rwigema JC , HeronDE, FerrisRLet al.: Fractionated stereotactic body radiation therapy in the treatment of previously-irradiated recurrent head and neck carcinoma – updated report of the University of Pittsburgh Cancer Experience.Am. J. Clin. Oncol. (2009) (Epub ahead of print).
  • Bonner JA , HarariPM, GiraltJet al.: Radiotherapy plus cetuximab for squamous-cell carcinoma of the head and neck.N. Engl. J. Med.354, 567–578 (2006).

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Order Reprints Request Corporate Permissions

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

Request Academic Permissions

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.

Related research

People also read lists articles that other readers of this article have read.

Recommended articles lists articles that we recommend and is powered by our AI driven recommendation engine.

Cited by lists all citing articles based on Crossref citations.
Articles with the Crossref icon will open in a new tab.